blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0880542

EP0880542 - SUBSTRATES AND INHIBITORS FOR CYSTEINE PROTEASE ICH-1 [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  18.06.2004
Database last updated on 19.10.2024
Most recent event   Tooltip18.06.2004Application deemed to be withdrawnpublished on 04.08.2004  [2004/32]
Applicant(s)For all designated states
Abbott GmbH & Co. KG
Max-Planck-Ring 2
65205 Wiesbaden / DE
For all designated states
WARNER-LAMBERT COMPANY
201 Tabor Road Morris Plains
New Jersey 07950 / US
[N/P]
Former [2003/36]For all designated states
ABBOTT GmbH & Co. KG
Max-Planck-Ring 2
65205 Wiesbaden / DE
For all designated states
WARNER-LAMBERT COMPANY
201 Tabor Road
Morris Plains New Jersey 07950 / US
Former [1998/49]For all designated states
BASF AG
c/o BASF Bioresearch Corportion, 100 Research Drive
Worcester, MA 01605-4314 / US
For all designated states
WARNER-LAMBERT COMPANY
201 Tabor Road
Morris Plains New Jersey 07950 / US
Inventor(s)01 / TALANIAN, Robert, V.
33 Candleberry Lane
Harvard, MA 01451 / US
02 / GHAYUR, Tariq
6 Oak Street
Grafton, MA 01519 / US
03 / HODGES, John, C.
4307 Walden Drive
Ann Arbor, MI 48105 / US
[1998/49]
Representative(s)Riedl, Peter, et al
Patentanwälte
Reitstötter, Kinzebach & Partner
Postfach 86 06 49
81633 München / DE
[N/P]
Former [2000/40]Riedl, Peter, Dr., et al
Patentanwälte Reitstötter, Kinzebach & Partner Postfach 86 06 49
81633 München / DE
Former [1998/49]Miller, Thomas Kerr, et al
BASF Aktiengesellschaft, Patent Department ZDX-C6
D-67056 Ludwigshafen / DE
Application number, filing date97906449.028.01.1997
[1998/49]
WO1997US01485
Priority number, dateUS1996059294329.01.1996         Original published format: US 592943
US1996066564318.06.1996         Original published format: US 665643
[1998/49]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9727220
Date:31.07.1997
Language:EN
[1997/33]
Type: A2 Application without search report 
No.:EP0880542
Date:02.12.1998
Language:EN
The application published by WIPO in one of the EPO official languages on 31.07.1997 takes the place of the publication of the European patent application.
[1998/49]
Search report(s)International search report - published on:EP25.09.1997
ClassificationIPC:C07K14/81, A61K38/04, G01N33/48, C07K1/22
[1998/49]
CPC:
C07K5/101 (EP,US); A61P25/28 (EP); A61P43/00 (EP);
C07K14/81 (EP,US); A61K38/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/49]
TitleGerman:SUBSTRATE UND HEMMER FÜR CYSTEINEPROTEASE ICH-1[1998/49]
English:SUBSTRATES AND INHIBITORS FOR CYSTEINE PROTEASE ICH-1[1998/49]
French:SUBSTRATS ET INHIBITEURS DE LA CYSTEINE PROTEASE ICH-1[1998/49]
Entry into regional phase24.08.1998National basic fee paid 
24.08.1998Designation fee(s) paid 
24.08.1998Examination fee paid 
Examination procedure26.08.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
24.08.1998Examination requested  [1998/49]
17.07.2003Despatch of a communication from the examining division (Time limit: M06)
27.01.2004Application deemed to be withdrawn, date of legal effect  [2004/32]
02.03.2004Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2004/32]
Fees paidRenewal fee
25.01.1999Renewal fee patent year 03
27.12.1999Renewal fee patent year 04
05.01.2001Renewal fee patent year 05
10.01.2002Renewal fee patent year 06
20.01.2003Renewal fee patent year 07
05.01.2004Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]  - NICHOLSON, DONALD W. ET AL, "Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis", NATURE (LONDON), 376, 37-43, (19950706), XP002013934 [X] 1-35 * the whole document *

DOI:   http://dx.doi.org/10.1038/376037a0
 [X]  - PINILLA, CLEMENCIA ET AL, "Investigation of antigen-antibody interactions using a soluble, non-support-bound synthetic decapeptide library composed of four trillion (4.times. 1012) sequences", BIOCHEM. J., 301(3), 847-53, (1994), XP000654979 [X] 1-3,16-18 * table 3 *
 [X]  - WANG, XIAODONG ET AL, "Purification of an interleukin -1.beta. converting enzyme-related cysteine protease that cleaves sterol regulatory element-binding proteins between the leucine zipper and transmembrane domains", J. BIOL. CHEM., 270(30), (1995), pages 18044 - 18050, XP000616151 [X] 1-35 * abstract *

DOI:   http://dx.doi.org/10.1074/jbc.270.30.18044
 [PX]  - FUJITA, ERIKO ET AL, "Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors", BIOCHEM. BIOPHYS. RES. COMMUN., (1996), vol. 224, no. 1, pages 74 - 79, XP000652324 [PX] 1-35 * page 75 *

DOI:   http://dx.doi.org/10.1006/bbrc.1996.0986
 [PX]  - FERNANDES-ALNEMRI, TERESA ET AL, "In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains", PROC. NATL. ACAD. SCI. U. S. A., 93(15), 7464-7469, (19960723), XP000616167 [PX] 1-35 * abstract *

DOI:   http://dx.doi.org/10.1073/pnas.93.15.7464
 [PX]  - DUBREZ, LAURENCE ET AL, "Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways", EMBO J., 15(20), 5504-5512, (1996), XP000652323 [PX] 1-35 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.